Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 1.94% |
| 2 | Technology | 1.9% |
| 3 | Communication Services | 1.42% |
| 4 | Financials | 1.08% |
| 5 | Healthcare | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
CALL
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$100M
| $27M | ﹤0.01% |
200,900
-120,100
| -37% | -$13.9M |
|
1677
Vuzix
VUZI
$231M
| $27M | ﹤0.01% |
1,472,744
+392,502
| +36% | +$7.92M |
|
1678
PUT
Quest Diagnostics
DGX
$27B
| $27M | ﹤0.01% |
204,500
+125,100
| +158% | +$16.4M |
|
1679
CALL
Sarepta Therapeutics
SRPT
$2B
| $27M | ﹤0.01% |
346,800
+48,300
| +16% | +$3.66M |
|
1680
PUT
British American Tobacco
BTI
$122B
| $27M | ﹤0.01% |
685,700
+128,200
| +23% | +$5.02M |
|
1681
PUT
Canadian National Railway
CNI
$76.9B
| $26.9M | ﹤0.01% |
255,100
+241,700
| +1,804% | +$26.7M |
|
1682
CALL
STAAR Surgical
STAA
$1.16B
| $26.9M | ﹤0.01% |
176,500
-49,800
| -22% | -$6.56M |
|
1683
Affirm
AFRM
$26.1B
| $26.9M | ﹤0.01% |
398,811
+82,258
| +26% | +$5.25M |
|
1684
Truist Financial
TFC
$61.4B
| $26.8M | ﹤0.01% |
482,665
+162,386
| +51% | +$9.54M |
|
1685
CALL
Upwork
UPWK
$1.09B
| $26.8M | ﹤0.01% |
459,100
-165,800
| -27% | -$7.79M |
|
1686
CALL
Ecolab
ECL
$81.2B
| $26.8M | ﹤0.01% |
129,900
+40,300
| +45% | +$8.76M |
|
1687
PUT
Charles River Laboratories
CRL
$14.2B
| $26.7M | ﹤0.01% |
72,300
+18,100
| +33% | +$6.04M |
|
1688
Magnite
MGNI
$3.43B
| $26.7M | ﹤0.01% |
787,679
-331,863
| -30% | -$11.2M |
|
1689
CALL
Stanley Black & Decker
SWK
$14.9B
| $26.6M | ﹤0.01% |
130,000
-71,200
| -35% | -$14.8M |
|
|
1690
CALL
Quest Diagnostics
DGX
$27B
| $26.6M | ﹤0.01% |
201,900
+96,600
| +92% | +$12.6M |
|
|
JOYY
1691
CALL
JOYY Inc
JOYY
$3.78B
| $26.6M | ﹤0.01% |
403,600
-98,900
| -20% | -$8.4M |
|
1692
PUT
PPG Industries
PPG
$25.3B
| $26.6M | ﹤0.01% |
156,800
+22,500
| +17% | +$3.86M |
|
1693
Baxter International
BAX
$13.6B
| $26.6M | ﹤0.01% |
330,667
+88,813
| +37% | +$7.45M |
|
1694
PUT
Royal Bank of Canada
RY
$284B
| $26.6M | ﹤0.01% |
262,200
+26,000
| +11% | +$2.58M |
|
|
FSR
1695
DELISTED
Fisker Inc.
FSR
| $26.5M | ﹤0.01% |
1,374,956
+264,998
| +24% | +$3.91M |
|
1696
CALL
CF Industries
CF
$19.3B
| $26.5M | ﹤0.01% |
515,200
+134,100
| +35% | +$6.82M |
|
|
NBIS
1697
CALL
Nebius Group N.V.
NBIS
$60.3B
| $26.5M | ﹤0.01% |
374,400
-43,000
| -10% | -$2.82M |
|
1698
CALL
Ambarella
AMBA
$3.1B
| $26.5M | ﹤0.01% |
248,400
+37,000
| +18% | +$3.66M |
|
1699
Tyson Foods
TSN
$20.1B
| $26.5M | ﹤0.01% |
359,006
-209,898
| -37% | -$16.3M |
|
|
MAXR
1700
CALL
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $26.5M | ﹤0.01% |
663,300
+188,300
| +40% | +$6.7M |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.7% a quarter earlier, followed by Technology and Communication Services.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.